摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-amino-N-(1,2-diphenylethyl)-(S)-2-(N'-(4-methyl-1-naphthalenesulfonyl)amino)pentanamide | 849947-98-4

中文名称
——
中文别名
——
英文名称
5-amino-N-(1,2-diphenylethyl)-(S)-2-(N'-(4-methyl-1-naphthalenesulfonyl)amino)pentanamide
英文别名
(2S)-5-amino-N-(1,2-diphenylethyl)-2-[(4-methylnaphthalen-1-yl)sulfonylamino]pentanamide
5-amino-N-(1,2-diphenylethyl)-(S)-2-(N'-(4-methyl-1-naphthalenesulfonyl)amino)pentanamide化学式
CAS
849947-98-4
化学式
C30H33N3O3S
mdl
——
分子量
515.676
InChiKey
PRADZSLQSXYLIE-MBMZGMDYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.1
  • 重原子数:
    37
  • 可旋转键数:
    11
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.23
  • 拓扑面积:
    110
  • 氢给体数:
    3
  • 氢受体数:
    5

文献信息

  • SOMATOSTATIN RECEPTOR 1 AND/OR 4 SELECTIVE AGONISTS AND ANTAGONISTS
    申请人:Wurster, Siegfried
    公开号:EP1675824B1
    公开(公告)日:2010-09-29
  • Somatostatin receptor 1 and/or 4 selective agonists and antagonists
    申请人:Tomperi Jussi
    公开号:US20070129422A1
    公开(公告)日:2007-06-07
    The invention relates to (hetero)arylsulfonylamino based peptidomimetics of formula (I), wherein R1, R2, R3, A, B, D, Q, k and n are defined as disclosed, or a pharmaceutically acceptable salt or ester thereof. Compounds of formula (I) possess high affinity and selectivity for the somatostatin receptor subtypes SSTR1 and/or SSTR4 and can be used for the treatment or diagnosis of diseases or conditions wherein an interaction with SSTR1 and/or SSTR4 is indicated to be useful.
  • Somatostatin Receptor 1 and/or 4 Selective Agonists and Antagonists
    申请人:Tomperi Jussi
    公开号:US20100004339A1
    公开(公告)日:2010-01-07
    The invention relates to (hetero)arylsulfonylamino based peptidomimetics of formula (I), wherein R1, R2, R3, A, B, D, Q, k and n are defined as disclosed, or a pharmaceutically acceptable salt or ester thereof. Compounds of formula (I) possess high affinity and selectivity for the somatostatin receptor subtypes SSTR1 and/or SSTR4 and can be used for the treatment or diagnosis of diseases or conditions wherein an interaction with SSTR1 and/or SSTR4 is indicated to be useful.
  • US7741362B2
    申请人:——
    公开号:US7741362B2
    公开(公告)日:2010-06-22
查看更多